Access to Medicare Data Act of 2007

MMM (Legislative Issues): H.R. 4: Medicare Prescription Drug Price Negotiation Act (Dingell); H.R. 976: Childrens Health Insurance Program Reauthorization Act (Rangel) (continued) H.R. 1990: Medicare Cost Contract Extension and Refinement Act (Pomeroy); H.R. 2945: Medicare Advantage Truth in Advertising Act (Stark); H.R. 3025: Medicare Prescription Drug Savings for Our Seniors Act (Doggett); H.R. 3061: Medicare Part D Drug Class Protection Act (Doggett); H.R. 3162: Childrens Health and Medicare Protection Act (Dingell); H.R. 3932: Medicare Prescription Drug Savings and Choice Act (Berry); H.R. 3963: Childrens Health Insurance Program Reauthorization Act (Dingell); H.R. 4296: Medicare Electronic Medication and Safety Protection Act (Schwartz); H.R. 5268: Medicaid FMAP (Pallone); H.R. 5480: Medicare Funding Warning Response Act (Hoyer-Boehner); H.R. 5613: Protecting the Medicaid Safety Net Act (Dingell); H.R. 5683: GAO Act (provisions relating to access to Medicare part C/part D data) (Davis); H.R. 5998: Protecting Children's Health Coverage Act (Pallone); H.R. 6331: Medicare Improvements for Patients and Providers Act (provisions relating to Medicare Advantage, Medicare Part D, Medigap, Medicaid, health care disparities, and electronic prescribing) (Rangel-Dingell); H.R. 6388: GAO Improvement Act (provisions relating to access to Medicare part C/part D data) (Waxman); H.R. 6359: Medicare Beneficiary Protection Act (Biggert); H.R. 6365: Medicare Special Needs Plans Extension and Amendments Act (Kind); H.R. 7077: QI Program Supplemental Funding Act (Dingell) (provisions relating to cost sharing assistance for low-income Medicare beneficiaries); H.R. 7197: Medicare Advantage Funding (Gonzalez) (provisions relating to limiting increases in Medicare Advantage payment rates); H.Res. 1368 (provisions relating to Medicare Funding Warning); S. 3: Medicare Prescription Drug Price Negotiation Act (Reid); S. 130: Medicare Cost Contract Extension and Refinement Act (Allard); S. 706: Medicare Advantage Stabilization Fund (Feingold); S. 799: Community Choice Act (Harkin); S. 1102: Part D Equity for Low-Income Seniors Act (Bingaman); S. 1103: Helping Fill the Medicare Rx Gap Act (Bingaman); S. 1107: Home and Community Services Copayment Equity Act (Smith); S. 1108: Medicare Part D Outreach and Enrollment Enhancement Act (Smith); S. 1200: Indian Health Care Improvement Act (includes Medicaid/MA provisions); S. 1507: Access to Medicare Data Act (Grassley); S. 1544: Medicare Quality Enhancement Act (Gregg); S. 1589: Drug Rebate Equalization Act (Bingaman) (provisions relating to Medicaid drug rebates); S. 1827: Pharmacist Access and Recognition in Medicare Act (Cochran); S. 1893: Childrens Health Insurance Program Reauthorization Act (Baucus); S. 1954: Pharmacy Access Improvement Act (Baucus); S. 2219: Medicare Prescription Drug Savings and Choice Act (Durbin); S. 2408: Medicare Electronic Medication and Safety Protection Act (Kerry); S. 2620: Medicaid FMAP (Rockefeller); S. 2662: Medicare Funding Warning Response Act (Baucus-Gregg); S. 2795: Small Business Health Options Program Act (Durbin-Snowe); S. 2819: Economic Recovery in Health Care Act (provisions relating to Medicaid funding) (Rockefeller); S. 3101: Medicare Improvements for Patients and Providers Act (provisions relating to Medicare Advantage, Medicare Part D, Medigap, Medicaid, health care disparities, electronic prescribing) (Baucus); S. 3560: QI Program Supplemental Funding Act (Baucus) (provisions relating to cost sharing assistance for low-income Medicare beneficiaries); S. 3604: Emergency Supplemental Appropriations Act (provisions relating to Medicaid FMAP); S. 3656: Preserving Access to Healthcare Act (Schumer) (provisions relating to Medicare and Medicaid regulation); S. 3869: Economic Stimulus (Reid) (provisions relating to Medicaid FMAP and Medicaidd MCO provider taxes); S. 3710: Medicare Early Access Act (Rockefeller) (provisions relating to Medicare "buy-in" option); and S.J.Res. 44 (provisions relating to blocking implementation of SCHIP requirements). MMM (Regulatory Issues) Ongoing implementation issues for the Medicare Advantage (MA) and Medicare Part D prescription drug programs, including risk adjustment methodology and data issues, (including audit and encounter data issues), bidding and payment issues (including MA coding intensity, Part D reinsurance, low income subsidies, application process, and audits), application process, audits to evaluate compliance with MA and Part D program rules, benefit design rules, SSA and CMS premium withhold processing issues, enrollment rules, marketing materials review and approval, marketing activities, including conduct and compensation of brokers and agents and plan sponsor marketing staff, measurement and oversight of plan performance including Special Needs Plans (SNPs); quality meaasures, grievance and appeals processes, compliance/fraud and abuse training, and Medicare/Medicaid integration issues for Special Needs Plans (SNPs); Federal premption of State authority over MA and Part D plans, Part D prescription drug event data reporting, Part D formulary rules, Part D pharmacy access standards, and other operational issues; Medicare creditable drug coverage reporting requirements; implementation issues for the Medicare Retiree Drug Subsidy program; functionality of the Medicare Personal Plan Finder and Drug Plan Finder; National Medicare Education program; ongoing implementation issues for the Medicare cost plan program including enrollment, marketing materials review and approval and other operational issues, MA and Part D systems issues affecting enrollment and disenrollment processing and payment and other operational issues; Medicare demonstration program on performance-based payments for physician groups; physician quality reporting inititiative; issues relating to Medicare coverage policy and national coverage decisions; Medicare clinical trials; Medicaid managed care regulations and policies, including the Medicaid managed care actuarial soundness standard, quality oversight, grievance and appeals processes, beneficiary information requirements, treatment of Medicaid health plan member hospital days in the upper payment limit calculation; policies affecting State Medicaid funding, including intergovernmental transfers (IGTs); coordination of benefits with state Medicaid programs; Medicaid prescription drug cost/rebate issues affecting Medicaid health plans; health plan-related State Childrens Health Insurance Program (SCHIP) issues, including eligibility and outreach issues; implementation of Medicaid changes made in Deficit Reduction Act of 2005, including documentation of citizenship requirements, state benefit flexibility options, and Medicaid managed care organization provider tax issues; standards for electronic prescribing; and health information technology standards and policies.

Client expense: $2,240,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Office of Personnel Management (OPM), SENATE, Social Security Administration (SSA), Treasury, Dept of

HR 2945 - Medicare Advantage Truth in Advertising Act; HR 2642 - Supplemental Appropriations for FY 2008; HR 4296 - Medicare Electronic Medication and Safety Protection Act; HR 5613 - Protecting the Medicaid Safety Net Act; HR 6331 - Medicare Improvements for Patients and Providers Act of 2008; HR 6365 - Medicare Special Needs Plans Extension and Amendments Act of 2008; S 1507 - Access to Medicare Data Act; S 1544 - Medicare Quality Enhancement Act; S 1954 - Pharmacy Access Improvement Act; S 2408 - Medicare Electronic Medication and Safety Protection Act; S 3101 - Medicare Improvements for Patients and Providers Act of 2008; S 3560 - QI Program Supplemental Funding Act of 2008; HR 2638 - Consolidated Security, Disaster Assistance and Continuing Appropriations Act; S 3236 - The Medicare and Medicaid Extensions Act of 2008; HR 2 - Children's Health Insurance Program Reauthorization Act of 2008

Client expense: $800,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of

Medicare Advantage program - Proposed legislation concerning this issue. Medicare/Medicaid issues - HR 4, Medicare Prescription Drug Price Negotiation Act of 2007; S 3, Medicare Prescription Drug Price Negotiation Act of 2007; S 1102, Part D Equity for Low-Income Seniors Act of 2007; S 1103, Helping Fill the Medicare Rx Gap Act of 2007; S 1107, Home and Community Services Copayment Equity Act of 2007; S 1108, Medicare Part D Outreach and Enrollment Enhancement Act of 2007; HR 2945, Medicare Advantage Truth in Advertising Act of 2007; S 799, Community Choice Act of 2007; S 1544, Medicare Quality Enhancement Act of 2007; S 1507, Access to Medicare Data Act of 2007; S 1827, Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007; HR 3025, Medicare Prescription Drug Savings for Our Seniors (Medicare Prescription Drug SOS) Act of 2007; HR 3061, Medicare Part D Drug Class Protection Act of 2007; HR 3162, Children's Health and Medicare Protection Act of 2007; HR 976, Children's Health Insurance Program Reauthorization Act of 2007; S 1893, Children's Health Insurance Program Reauthorization Act of 2007; S 1954, Pharmacy Access Improvement (PhAIm) Act of 2007; HR 3963, Children's Health Insurance Program Reauthorization Act of 2007; S 2219, Medicare Prescription Drug Savings and Choice Act of 2007; HR 3932, Medicare Prescription Drug Savings and Choice Act of 2007; S 2408, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; HR 4296, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; S 1200, Indian Health Care Improvement Act Amendments of 2008; HR 5480, Medicare Funding Warning Response Act of 2008; S 2662, Medicare Funding Warning Response Act of 2008; HR 5268, To provide for a temporary increase of the Federal medical assistance percentage under the Medicaid Program; HR 6388, Government Accountability Office Improvement Act of 2008; HR 5998, Fair and Justifiable Credit Card Interest Rate Act of 2008; S 2819, Economic Recovery in Health Care Act of 2008; HR 6359, Medicare Beneficiary Protection Act of 2008; HR 6365, Medicare Special Needs Plans Extension and Amendments Act of 2008; HR 5613, Protecting the Medicaid Safety Net Act of 2008; S 2620, To provide for a temporary increase of the Federal medical assistance percentage under the Medicaid program; HR 5683, Government Accountability Office Act of 2008; HR 7110, Job Creation and Unemployment Relief Act of 2008; S 3560, QI Program Supplemental Funding Act of 2008; HR 7077, QI Program Supplemental Funding Act of 2008; S 3604, Emergency Supplemental; HR 7197, To amend part C of title XVIII of the Social Security Act to limit increases in Medicare Advantage payment rates; S 3656, Preserving Access to Healthcare (PATH) Act of 2008; S 3689, Economic Stimulus; S 3710, Medicare Early Access Act of 2008; S 3101, Medicare Improvements for Patients and Providers Act of 2008.

Client expense: Not reported · Firm income: $100,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to drug coverage including pharmacy payments, reimbursement, competition and plan administration; Health Information Technology with respect to data privacy and electronic prescribing of prescription drugs; Promotion of competition in the prescription drug marketplace including the drug approval process; Additional Issues - see addendum Issues related to drug coverage including pharmacy payments, reimbursement, competition and plan administration HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; HR 3140 - Saving Our Community Pharmacies Act of 2007 HR 3193 - Access to Community Pharmacy Preservation Act of 2007 S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007 S 2161 - Community Pharmacy Fairness Act of 2007 Health information technology with respect to data privacy and electronic prescribing of prescription drugs HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007 HR 3800 - Promoting Health Information Technology Act HR 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or the PRO(TECH) Act of 2008 HR 6898 - Health e-Information Technology Act S 1408 - Health Information Technology Act of 2007 S 1693 - Wired for Health Care Quality Act S. 1814 - Health Information Privacy and Security Act Promotion of competition in the prescription drug marketplace including the drug approval process HR 1432 and S. 316 - Preserve Access to Affordable Generics Act HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 HR 5629 - Pathway for Biosimilars Act S 28 - Generics First Act of 2007 S 1695 - Biologics Price Competition and Innovation Act of 2007 HR 1038 / S 623 - Access to Life-Saving Medicine Act S 316 Preserve Access to Affordable Generics Act HR 1505 / S 1695 Affordable Biologics for Consumers Act HR 5629 - Pathway for Biosimilars Act Additional Issues HR 5683 - Government Accountability Office Act of 2008 S 1507 - Access to Medicare Data Act of 2007 S 273 - Prescription Drug and Health Improvement Act of 2007 HR 3610 - Food and Drug Import Safety Act of 2007

Client expense: $314,868 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE, White House Office

Issues related to Medicare/Medicaid drug coverage including pharmacy payments, reimbursements, competition and plan administration; electronic prescribing. S 3 / HR 4 - Medicare Prescription Drug Price Negotiation Act of 2007 HR 3700 - Fair Medicaid Drug Payment Act of 2007 S 273 - Prescription Drug and Health Improvement Act of 2007 S 3118 - Preserving Access to Medicare Act of 2008 HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007 HR 6331 - Medicare Improvement for Patients and Providers Act of 2008 S 3101 - Medicare Improvements for Patients and Providers Act of 2008 S 1951 - Fair Medicaid Drug Payment Act of 2007 HR 3140 - Saving Our Community Pharmacies Act of 2007 S 1507 - Access to Medicare Data Act of 2007

Client expense: $314,868 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE, White House Office

Issues related to Medicare/Medicaid drug coverage including pharmacy payments, reimbursements, competition and plan administration; electronic prescribing S 3 / HR 4 - Medicare Prescription Drug Price Negotiation Act of 2007 HR 3700 - Fair Medicaid Drug Payment Act of 2007 S 273 - Prescription Drug and Health Improvement Act of 2007 S 3118 - Preserving Access to Medicare Act of 2008 HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007 HR 6331 - Medicare Improvement for Patients and Providers Act of 2008 S 3101 - Medicare Improvements for Patients and Providers Act of 2008 S 1951 - Fair Medicaid Drug Payment Act of 2007 HR 3140 - Saving Our Community Pharmacies Act of 2007 S 1507 - Access to Medicare Data Act of 2007

Client expense: $324,944 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE, White House Office

Issues related to drug coverage including pharmacy payments, reimbursement, competition and plan administration; Health Information Technology with respect to data privacy and electronic prescribing of prescription drugs; Promotion of competition in the prescription drug marketplace including the drug approval process; Additional Issues - see addendum Issues related to drug coverage including pharmacy payments, reimbursement, competition and plan administration HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; HR 3140 - Saving Our Community Pharmacies Act of 2007 HR 3193 - Access to Community Pharmacy Preservation Act of 2007 S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007 S 2161 - Community Pharmacy Fairness Act of 2007 Health information technology with respect to data privacy and electronic prescribing of prescription drugs HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007 HR 3800 - Promoting Health Information Technology Act HR 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or the PRO(TECH) Act of 2008 HR 6898 - Health e-Information Technology Act S 1408 - Health Information Technology Act of 2007 S 1693 - Wired for Health Care Quality Act S. 1814 - Health Information Privacy and Security Act Promotion of competition in the prescription drug marketplace including the drug approval process HR 1432 and S. 316 - Preserve Access to Affordable Generics Act HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 HR 5629 - Pathway for Biosimilars Act S 28 - Generics First Act of 2007 S 1695 - Biologics Price Competition and Innovation Act of 2007 HR 1038 / S 623 - Access to Life-Saving Medicine Act S 316 Preserve Access to Affordable Generics Act HR 1505 / S 1695 Affordable Biologics for Consumers Act HR 5629 - Pathway for Biosimilars Act Additional Issues HR 5683 - Government Accountability Office Act of 2008 S 1507 - Access to Medicare Data Act of 2007 S 273 - Prescription Drug and Health Improvement Act of 2007 HR 3610 - Food and Drug Import Safety Act of 2007

Client expense: $324,944 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE, White House Office

Medicare Advantage - HR 6331, Medicare Improvements for Patients and Providers Act of 2008; Proposed legislation re this issue. Medigap insurance market issues - Proposed legislation re these issues. Medicare/Medicaid issues - S 706, To amend title XVIII of the Social Security Act to repeal the MA Regional Plan Stabilization Fund; S 130, Medicare Cost Contract Extension and Refinement Act of 2007; HR 1990, Medicare Cost Contract Extension and Refinement Act of 2007; HR 4, Medicare Prescription Drug Price Negotiation Act of 2007; S 3, Medicare Prescription Drug Price Negotiation Act of 2007; S 1102, Part D Equity for Low-Income Seniors Act of 2007; S 1103, Helping Fill the Medicare Rx Gap Act of 2007; S 1107, Home and Community Services Copayment Equity Act of 2007; S 1108, Medicare Part D Outreach and Enrollment Enhancement Act of 2007; HR 2945, Medicare Advantage Truth in Advertising Act of 2007; S 799, Community Choice Act of 2007; S 1544, Medicare Quality Enhancement Act of 2007; S 1507, Access to Medicare Data Act of 2007; S 1827, Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007; HR 3025, Medicare Prescription Drug Savings for Our Seniors (Medicare Prescription Drug SOS) Act of 2007; HR 3061, Medicare Part D Drug Class Protection Act of 2007; HR 3162, Children's Health and Medicare Protection Act of 2007; HR 976, Children's Health Insurance Program Reauthorization Act of 2007; S 1893, Children's Health Insurance Program Reauthorization Act of 2007; S 1954, Pharmacy Access Improvement (PhAIm) Act of 2007; HR 3963, Children's Health Insurance Program Reauthorization Act of 2007; S 2219, Medicare Prescription Drug Savings and Choice Act of 2007; HR 3932, Medicare Prescription Drug Savings and Choice Act of 2007; S 2408, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; HR 4296, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; S 1200, Indian Health Care Improvement Act Amendments of 2008; HR 5480, Medicare Funding Warning Response Act of 2008; S 2662, Medicare Funding Warning Response Act of 2008; HR 5268, To provide for a temporary increase of the Federal medical assistance percentage under the Medicaid Program; HR 6388, Government Accountability Office Improvement Act of 2008; HR 5998, Fair and Justifiable Credit Card Interest Rate Act of 2008; S 2819, Economic Recovery in Health Care Act of 2008; HR 6359, Medicare Beneficiary Protection Act of 2008; HR 6365, Medicare Special Needs Plans Extension and Amendments Act of 2008; HR 5613, Protecting the Medicaid Safety Net Act of 2008; S 2620, To provide for a temporary increase of the Federal medical assistance percentage under the Medicaid program; S 3101, Medicare Improvements for Patients and Providers Act of 2008; HR 5683, Government Accountability Office Act of 2008; HR 7110, Job Creation and Unemployment Relief Act of 2008; S 3560, QI Program Supplemental Funding Act of 2008; HR 7077, QI Program Supplemental Funding Act of 2008; SJRes 44, blocking implementation of SCHIP; HRes 1368, Resolved, That section 803 of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 shall not apply during the remainder of the 110th Congress; S 3604, Emergency Supplemental.

Client expense: Not reported · Firm income: $100,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office

HR 2945 - Medicare Advantage Truth in Advertising Act; HR 2642 - Supplemental Appropriations for FY 2008; HR 4296 - Medicare Electronic Medication and Safety Protection Act; HR 5613 - Protecting the Medicaid Safety Net Act; HR 6331 - Medicare Improvements for Patients and Providers Act of 2008; HR 6365 - Medicare Special Needs Plans Extension and Amendments Act of 2008; S 1507 - Access to Medicare Data Act; S 1544 - Medicare Quality Enhancement Act; S 1954 - Pharmacy Access Improvement Act; S 2408 - Medicare Electronic Medication and Safety Protection Act; S 3101 - Medicare Improvements for Patients and Providers Act of 2008; S 3560 - QI Program Supplemental Funding Act of 2008; HR 2638 - Consolidated Security, Disaster Assistance and Continuing Appropriations Act

Client expense: $970,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of

MMM (Legislative Issues): H.R. 4: Medicare Prescription Drug Price Negotiation Act (Dingell); H.R. 976: Childrens Health Insurance Program Reauthorization Act (Rangel) (continued) H.R. 1990: Medicare Cost Contract Extension and Refinement Act (Pomeroy); H.R. 2945: Medicare Advantage Truth in Advertising Act (Stark); H.R. 3025: Medicare Prescription Drug Savings for Our Seniors Act (Doggett); H.R. 3061: Medicare Part D Drug Class Protection Act (Doggett); H.R. 3162: Childrens Health and Medicare Protection Act (Dingell); H.R. 3932: Medicare Prescription Drug Savings and Choice Act (Berry); H.R. 3963: Childrens Health Insurance Program Reauthorization Act (Dingell); H.R. 4296: Medicare Electronic Medication and Safety Protection Act (Schwartz); H.R. 5268: Medicaid FMAP (Pallone); H.R. 5480: Medicare Funding Warning Response Act (Hoyer-Boehner); H.R. 5613: Protecting the Medicaid Safety Net Act (Dingell); H.R. 5683: GAO Act (provisions relating to access to Medicare part C/part D data) (Davis); H.R. 5998: Protecting Children's Health Coverage Act (Pallone); H.R. 6331: Medicare Improvements for Patients and Providers Act (provisions relating to Medicare Advantage, Medicare Part D, Medigap, Medicaid, health care disparities, and electronic prescribing) (Rangel-Dingell); H.R. 6388: GAO Improvement Act (provisions relating to access to Medicare part C/part D data) (Waxman); H.R. 6359: Medicare Beneficiary Protection Act (Biggert); H.R. 6365: Medicare Special Needs Plans Extension and Amendments Act (Kind); H.R. 7077: QI Program Supplemental Funding Act (Dingell) (provisions relating to cost sharing assistance for low-income Medicare beneficiaries); H.Res. 1368 (provisions relating to Medicare Funding Warning); S. 3: Medicare Prescription Drug Price Negotiation Act (Reid); S. 130: Medicare Cost Contract Extension and Refinement Act (Allard); S. 706: Medicare Advantage Stabilization Fund (Feingold); S. 799: Community Choice Act (Harkin); S. 1102: Part D Equity for Low-Income Seniors Act (Bingaman); S. 1103: Helping Fill the Medicare Rx Gap Act (Bingaman); S. 1107: Home and Community Services Copayment Equity Act (Smith); S. 1108: Medicare Part D Outreach and Enrollment Enhancement Act (Smith); S. 1200: Indian Health Care Improvement Act (includes Medicaid/MA provisions); S. 1507: Access to Medicare Data Act (Grassley); S. 1544: Medicare Quality Enhancement Act (Gregg); S. 1827: Pharmacist Access and Recognition in Medicare Act (Cochran); S. 1893: Childrens Health Insurance Program Reauthorization Act (Baucus); S. 1954: Pharmacy Access Improvement Act (Baucus); S. 2219: Medicare Prescription Drug Savings and Choice Act (Durbin); S. 2408: Medicare Electronic Medication and Safety Protection Act (Kerry); S. 2620: Medicaid FMAP (Rockefeller); S. 2662: Medicare Funding Warning Response Act (Baucus-Gregg); S. 2795: Small Business Health Options Program Act (Durbin-Snowe); S. 2819: Economic Recovery in Health Care Act (provisions relating to Medicaid funding) (Rockefeller); S. 3101: Medicare Improvements for Patients and Providers Act (provisions relating to Medicare Advantage, Medicare Part D, Medigap, Medicaid, health care disparities, electronic prescribing) (Baucus); S. 3560: QI Program Supplemental Funding Act (Baucus) (provisions relating to cost sharing assistance for low-income Medicare beneficiaries); S. 3604: Emergency Supplemental Appropriations Act (provisions relating to Medicaid FMAP); and S.J.Res. 44 (provisions relating to blocking implementation of SCHIP requirements). MMM (Regulatory Issues) Ongoing implementation issues for the Medicare Advantage (MA) and Medicare Part D prescription drug programs, including risk adjustment methodology and data issues, (including audit and encounter data issues) bidding and payment issues (including MA coding intensity, Part D reinsurance, low income subsidies, application process, and audits), application process, and audits, benefit design rules, SSA and CMS premium withhold processing issues, systems issues affecting enrollment and disenrollment processing, enrollment rules, marketing materials review and approval, marketing activities, including conduct and compensation of brokers and agents and plan sponsor marketing staff, measurement and oversight of plan performance including Special Needs Plans (SNPs); grievance and appeals processes, compliance/fraud and abuse training, and Medicare/Medicaid integration issues for Special Needs Plans (SNPs); Federal premption of State authority over MA and Part D plans, Part D prescription drug event data reporting, Part D formulary rules, Part D pharmacy access standards, and other operational issues; Medicare creditable drug coverage reporting requirements; implementation issues for the Medicare Retiree Drug Subsidy program; functionality of the Medicare Personal Plan Finder and Drug Plan Finder; National Medicare Education program; ongoing implementation issues for the Medicare cost plan program including enrollment, marketing materials review and approval, systems issues affecting enrollment and disenrollment processing, payment and other operational issues; Medicare demonstration program on performance-based payments for physician groups; physician quality reporting inititiative; issues relating to Medicare coverage policy and national coverage decisions; Medicare clinical trials; Medicaid managed care regulations and policies, including the Medicaid managed care actuarial soundness standard, quality oversight, grievance and appeals processes, beneficiary information requirements, treatment of Medicaid health plan member hospital days in the upper payment limit calculation; policies affecting State Medicaid funding, including intergovernmental transfers (IGTs); coordination of benefits with state Medicaid programs; Medicaid prescription drug cost/rebate issues affecting Medicaid health plans; health plan-related State Childrens Health Insurance Program (SCHIP) issues, including eligibility and outreach issues; implementation of Medicaid changes made in Deficit Reduction Act of 2005, including documentation of citizenship requirements, state benefit flexibility options, and Medicaid managed care organization provider tax issues; standards for electronic prescribing; and health information technology standards and policies.

Client expense: $1,630,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Office of Personnel Management (OPM), SENATE, Social Security Administration (SSA), Treasury, Dept of

Medicare Part D: prompt pay/EFT for pharmacies (HR 1474/S 1827/S 1954/HR 6331), Changes to the part D benefit (HR 3162/S 2499/HR 6331), Electronic prescribing and eRx for controlled substances (HR 4296/S 2408/HR 6331), access to Medicare Data (HR 6388/S 1507/HR 6331), various regulatory issues related to Part D benefit. Medicare Part B: Changes to the competitive acquisition program for biologics (HR 3162) and prompt pay exclusion for distribution (HR 2770); AMP changes (HR 6331)

Client expense: $240,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE

Medicare Part D, Prompt Payment of Pharmacy Claims, Antitrust Exemption for Independent Pharmacists, IVIG Payments, Medicare Demonstration Project for Durable Medical Equipment HR 2567 and S 870 - Medicare Home Infusion Therapy Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 3700 - Fair Medicaid Drug Payment Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects HR 6252 and S 3144 - Medicare DMEPOS Competitive Acquisition Reform Act of 2008; all aspects HR 6331 - Medicare Improvement for Patients and Providers Act of 2008; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects S 1507 - Access to Medicare Data Act of 2007; all aspects S 2219 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects S 3101 - Medicare Improvements for Patients and Providers Act of 2008; all aspects S 3118 - Preserving Access to Medicare Act of 2008; sections 132, 145, 161-167

Client expense: $434,097 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Health Information Technology, Electronic Prescribing, Inappropriate use of Human Growth Hormone, Comparative Effectiveness, 340B Program, Confidentiality of Health Information, Generic Drugs, Generic Biologics, Internet Pharmacies, Carve-out of Generic Drugs from State Generic Substitution Laws HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 1432 and S. 316 - Preserve Access to Affordable Generics Act; all aspects HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects HR 2567 and S 870 - Medicare Home Infusion Therapy Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects HR 3193 - Access to Community Pharmacy Preservation Act of 2007; all aspects HR 3800 - Promoting Health Information Technology Act; all aspects HR 3932 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects HR 5629 - Pathway for Biosimilars Act; all aspects HR 5683 - Government Accountability Office Act of 2008, section 721 HR 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or the PRO(TECH) Act of 2008; all aspects HR 6898 - Health e-Information Technology Act; all aspects S 28 - Generics First Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects S 596 - Safe Internet Pharmacy Act of 2007; section 511(c) S 976 - Genomics and Personalized Medicine Act of 2007; all aspects S 980 - Ryan Haight Online Pharmacy Consumer Protection Act of 2007; all aspects S 1408 - Health Information Technology Act of 2007; all aspects S 1507 - Access to Medicare Data Act of 2007; all aspects S 1693 - Wired for Health Care Quality Act; all aspects S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects S. 1814 - Health Information Privacy and Security Act; all aspects S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects S 2161 - Community Pharmacy Fairness Act of 2007; all aspects

Client expense: $434,097 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 2567 and S 870 - Medicare Home Infusion Therapy Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 3700 - Fair Medicaid Drug Payment Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects HR 6252 and S 3144 - Medicare DMEPOS Competitive Acquisition Reform Act of 2008; all aspects HR 6331 - Medicare Improvement for Patients and Providers Act of 2008; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects S 1507 - Access to Medicare Data Act of 2007; all aspects S 2219 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects S 3101 - Medicare Improvements for Patients and Providers Act of 2008; all aspects S 3118 - Preserving Access to Medicare Act of 2008; sections 132, 145, 161-167

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE

HR 1432 and S. 316 - Preserve Access to Affordable Generics Act; all aspects HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects HR 2567 and S 870 - Medicare Home Infusion Therapy Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects HR 3193 - Access to Community Pharmacy Preservation Act of 2007; all aspects HR 3800 - Promoting Health Information Technology Act; all aspects HR 3932 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects HR 5629 - Pathway for Biosimilars Act; all aspects HR 5683 - Government Accountability Office Act of 2008, section 721 HR 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or the PRO(TECH) Act of 2008; all aspects HR 6898 - Health e-Information Technology Act; all aspects S 28 - Generics First Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects S 596 - Safe Internet Pharmacy Act of 2007; section 511(c) S 976 - Genomics and Personalized Medicine Act of 2007; all aspects S 980 - Ryan Haight Online Pharmacy Consumer Protection Act of 2007; all aspects S 1408 - Health Information Technology Act of 2007; all aspects S 1507 - Access to Medicare Data Act of 2007; all aspects S 1693 - Wired for Health Care Quality Act; all aspects S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects S. 1814 - Health Information Privacy and Security Act; all aspects S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects S 2161 - Community Pharmacy Fairness Act of 2007; all aspects

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE

HR 2945 Medicare Advantage Truth in Advertising Act; HR 2642 Supplemental Appropriations for FY 2008; HR 4296 Medicare Electronic Medication and Safety Protection Act; HR 5613 Protecting the Medicaid Safety Net Act; HR 6331 Medicare Improvements for Patients and Providers Act of 2008; HR 6365 Medicare Special Needs Plans Extension and Amendments Act of 2008; H. Con Res 312 Budget Resolution; S 1507 Access to Medicare Data Act; S 1544 Medicare Quality Enhancement Act; S 1954 Pharmacy Access Improvement Act; S 2408 Medicare Electronic Medication and Safety Protection Act; S 3101 Medicare Improvements for Patients and Providers Act of 2008; H. Con. Res. 70 Budget Resolution

Client expense: $1,250,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Deposit Insurance Corporation (FDIC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of

MMM (Legislative Issues): H.R. 4: Medicare Prescription Drug Price Negotiation Act (Dingell); H.R. 976: Childrens Health Insurance Program Reauthorization Act (Rangel); H.R. 1535: Children's Health First Act (Dingell); H.R. 1663: Medicare Mental Health Modernization Act (Stark) (continued) H.R. 1990: Medicare Cost Contract Extension and Refinement Act (Pomeroy); H.R. 2147: Healthy Kids Act (Emanuel); H.R. 2945: Medicare Advantage Truth in Advertising Act (Stark); H.R. 2642: Supplemental Appropriations Act (provisions relating to moratoria on Medicaid regulations); H.R. 2842: Childrens Health Protection Act (Schwartz); H.R. 3025: Medicare Prescription Drug Savings for Our Seniors Act (Doggett); H.R. 3061: Medicare Part D Drug Class Protection Act (Doggett); H.R. 3162: Childrens Health and Medicare Protection Act (Dingell); H.R. 3195: ADA Amendments Act (Hoyer); H.R. 3932: Medicare Prescription Drug Savings and Choice Act (Berry); H.R. 3963: Childrens Health Insurance Program Reauthorization Act (Dingell); H.R. 4296: Medicare Electronic Medication and Safety Protection Act (Schwartz); H.R. 5268: Medicaid FMAP (Pallone); H.R. 5480: Medicare Funding Warning Response Act (Hoyer-Boehner); H.R. 5550: Coverage for Young Adult Dependents of Federal Employees (Davis); H.R. 5613: Protecting the Medicaid Safety Net Act (Dingell); H.R. 5683: GAO Act (provisions relating to access to Medicare part C/part D data) (Davis); H.R. 5781: Federal Employees Paid Parental Leave Act (Maloney); H.R. 5840: Insurance Information Act (Kanjorski); H.R. 5918: Small Business Health Options Program Act (Barrow); H.R. 5923: Patients Health Care Reform Act (Shadegg); H.R. 5955: Making Health Care More Affordable Act (Walberg); H.R. 5998: Protecting Children's Health Coverage Act (Pallone); H.R. 6071: Health Care Consumer Protection Act (provisions relating to reinstatement of health insurance following nonpayment of premiums) (Forbes); H.R. 6081: Heroes Earning Assistance and Relief Tax Act (mental health parity and FSA provisions); H.R. 6142: Lawsuits Against Employer-Sponsored Disability Benefit Plans (Andrews); H.R. 6210: Small Business Health Options Program Act (Kind-English); H.R. 6331: Medicare Improvements for Patients and Providers Act (provisions relating to Medicare Advantage, Medicare Part D, Medigap, Medicaid, health care disparities, and electronic prescribing) (Rangel-Dingell); H.R. 6388: GAO Improvement Act (provisions relating to access to Medicare part C/part D data) (Waxman); H.R. 6359: Medicare Beneficiary Protection Act (Biggert); H.R. 6365: Medicare Special Needs Plans Extension and Amendments Act (Kind); S. 3: Medicare Prescription Drug Price Negotiation Act (Reid); S. 130: Medicare Cost Contract Extension and Refinement Act (Allard); S. 401: Keep Children Covered Act (Rockefeller); S. 706: Medicare Advantage Stabilization Fund (Feingold); S. 799: Community Choice Act (Harkin); S. 895: Children's Health First Act (Clinton); S. 1102: Part D Equity for Low-Income Seniors Act (Bingaman); S. 1103: Helping Fill the Medicare Rx Gap Act (Bingaman); S. 1107: Home and Community Services Copayment Equity Act (Smith); S. 1108: Medicare Part D Outreach and Enrollment Enhancement Act (Smith); S. 1200: Indian Health Care Improvement Act (includes Medicaid/MA provisions); S. 1224: Children's Health Insurance Program Reauthorization Act (Rockefeller); S. 1507: Access to Medicare Data Act (Grassley); S. 1544: Medicare Quality Enhancement Act (Gregg); S. 1827: Pharmacist Access and Recognition in Medicare Act (Cochran); S. 1893: Childrens Health Insurance Program Reauthorization Act (Baucus); S. 1954: Pharmacy Access Improvement Act (Baucus); S. 2219: Medicare Prescription Drug Savings and Choice Act (Durbin); S. 2408: Medicare Electronic Medication and Safety Protection Act (Kerry); S. 2620: Medicaid FMAP (Rockefeller); S. 2662: Medicare Funding Warning Response Act (Baucus-Gregg); S. 2795: Small Business Health Options Program Act (Durbin-Snowe); S. 2819: Economic Recovery in Health Care Act (provisions relating to Medicaid funding) (Rockefeller); S. 2948: Small Business Empowerment Act (Brown); S. 2818: Small Business Health Plans Act (Enzi); S. 2999: Access to Cancer Clinical Trials Act (Brown); S. 3068: Equity in Prescription Insurance and Contraceptive Coverage Act (Snowe); S. 3101: Medicare Improvements for Patients and Providers Act (provisions relating to Medicare Advantage, Medicare Part D, Medigap, Medicaid, health care disparities, electronic prescribing) (Baucus); S. 3115: Childrens Health Protection Act (Lautenberg); S. 3118: Preserving Access to Medicare Act (provisions relating to Medicare Advantage, Medicare Part D, Medicaid, and electronic prescribing)(Grassley). MMM (Regulatory Issues) Ongoing implementation issues for the Medicare Advantage (MA) and Medicare Part D prescription drug programs, including risk adjustment methodology and data issues, (including encounter data issues) bidding and payment issues (including MA coding intensity, Part D reinsurance, low income subsidies, application process, and audits), application process, and audits, benefit design rules, SSA and CMS premium withhold processing issues, systems issues affecting enrollment and disenrollment processing, enrollment rules, marketing materials review and approval, marketing activities, including conduct of brokers and agents and plan sponsor marketing staff and issues raised by CMS about Private Fee-for-Service (PFFS) plan marketing, measurement and oversight of plan performance including Special Needs Plans (SNPs); grievance and appeals processes, compliance/fraud and abuse training, and Medicare/Medicaid integration issues for Special Needs Plans (SNPs); Federal premption of State authorization over MA and Part D plans, Part D prescription drug event data reporting, Part D formulary rules, Part D pharmacy access standards, and other operational issues; Medicare creditable drug coverage reporting requirements; implementation issues for the Medicare Retiree Drug Subsidy program; functionality of the Medicare Personal Plan Finder and Drug Plan Finder; National Medicare Education program; ongoing implementation issues for the Medicare cost plan program including enrollment, marketing materials review and approval, systems issues affecting enrollment and disenrollment processing, payment and other operational issues; Medicare demonstration program on performance-based payments for physician groups; physician quality reporting inititiative; issues relating to Medicare coverage policy and national coverage decisions; Medicare clinical trials; Medicaid managed care regulations and policies, including the Medicaid managed care actuarial soundness standard, quality oversight, grievance and appeals processes, beneficiary information requirements, treatment of Medicaid health plan member hospital days in the upper payment limit calculation; policies affecting State Medicaid funding, including intergovernmental transfers (IGTs) and federal matching funds for graduate medical education; coordination of benefits with state Medicaid programs; Medicaid prescription drug cost/rebate issues affecting Medicaid health plans; health plan-related State Childrens Health Insurance Program (SCHIP) issues, including eligibility and outreach issues; implementation of Medicaid changes made in Deficit Reduction Act of 2005, including documentation of citizenship requirements, state benefit flexibility options, and Medicaid managed care organization provider tax issues; standards for electronic prescribing; and health information technology standards and policies.

Client expense: $1,850,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Office of Personnel Management (OPM), SENATE, Social Security Administration (SSA), Treasury, Dept of

HR 2945 Medicare Advantage Truth in Advertising Act; HR 2642 Supplemental Appropriations for FY 2008; HR 4296 Medicare Electronic Medication and Safety Protection Act; HR 5613 Protecting the Medicaid Safety Net Act; HR 6331 Medicare Improvements for Patients and Providers Act of 2008; HR 6365 Medicare Special Needs Plans Extension and Amendments Act of 2008; H. Con Res 312 Budget Resolution; S 1507 Access to Medicare Data Act; S 1544 Medicare Quality Enhancement Act; S 1954 Pharmacy Access Improvement Act; S 2408 Medicare Electronic Medication and Safety Protection Act; S 3101 Medicare Improvements for Patients and Providers Act of 2008; H. Con. Res. 70 Budget Resolution

Client expense: $1,250,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Deposit Insurance Corporation (FDIC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of

Health Information Technology, Electronic Prescribing, Genetic Nondiscrimination, Inappropriate use of Human Growth Hormone, Medicare Part D Contract Disclsoure Requirements, Comparative Effectiveness, 340B Program, Confidentiality of Health Information, Generic Drugs, Generic Biologics, Internet Pharmacies, Off-Label Use of Prescription Drugs, Over-the-Counter Drug Dispersement, Carve-out of Generic Drugs from State Medicaid Generic Substitution Laws HR 493 and S 358 - Genetic Information Nondiscrimination Act of 2008; Title I HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 1432 and S. 316 - Preserve Access to Affordable Generics Act; all aspects HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects HR 2567 and S 870 - Medicare Home Infusion Therapy Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects HR 3193 - Access to Community Pharmacy Preservation Act of 2007; all aspects HR 3800 - Promoting Health Information Technology Act; all aspects HR 3932 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects HR 5629 - Pathway for Biosimilars Act; all aspects HR 5683 - Government Accountability Office Act of 2008, section 721 HR 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or the PRO(TECH) Act of 2008; all aspects S 28 - Generics First Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects S 596 - Safe Internet Pharmacy Act of 2007; section 511(c) S 976 - Genomics and Personalized Medicine Act of 2007; all aspects S 980 - Ryan Haight Online Pharmacy Consumer Protection Act of 2007; all aspects S 1408 - Health Information Technology Act of 2007; all aspects S 1507 - Access to Medicare Data Act of 2007; all aspects S 1693 - Wired for Health Care Quality Act; all aspects S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects S. 1814 - Health Information Privacy and Security Act; all aspects S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects S 2161 - Community Pharmacy Fairness Act of 2007; all aspects

Client expense: $508,492 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), SENATE

Medicare Part D, Prompt Payment of Pharmacy Claims, Antitrust Exemption for Independent Pharmacies, IVIG Payments, Tracking the Pedigree of Prescription Drugs, Reimportation of Prescription Drugs, Medicare Demonstration Project for Durable Medical Equipment HR 2567 and S 870 - Medicare Home Infusion Therapy Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 3700 - Fair Medicaid Drug Payment Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects HR 6252 and S 3144 - Medicare DMEPOS Competitive Acquisition Reform Act of 2008; all aspects HR 6331 - Medicare Improvement for Patients and Providers Act of 2008; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects S 1507 - Access to Medicare Data Act of 2007; all aspects S 2219 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects S 3101 - Medicare Improvements for Patients and Providers Act of 2008; all aspects S 3118 - Preserving Access to Medicare Act of 2008; sections 132, 145, 161-167

Client expense: $508,492 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), SENATE

Medicare Part D: prompt pay/EFT for pharmacies (HR 1474/S 1827/ S 1954/HR 6331), changes to the Part D benefit (HR 3162/S 2499/HR 6331), electronic prescribing (H.R. 4296/S 2408/ HR 6331), Access to Medicare Data (H.R. 6388/S 1507), various regulatory issues related to implementing the Medicare Part D benefit. Medicare Part B: Changes to the competitive acquisition program (HR 3162); prompt pay exculsion from Part B (HR 2770) Items related to the definition of Medicaid Average Manufacture Price (AMP) as espoused by the 2005 Deficit Reduction Act. (HR 3700/HR 6331)

Client expense: $210,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), SENATE, White House Office

HR 2567 and S 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 3700 - Fair Medicaid Drug Payment Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects HR 6252 and S 3144 - Medicare DMEPOS Competitive Acquisition Reform Act of 2008; all aspects HR 6331 - Medicare Improvement for Patients and Providers Act of 2008; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects S 1507 - Access to Medicare Data Act of 2007; all aspects S 2219 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects S 3101 - Medicare Improvements for Patients and Providers Act of 2008; all aspects S 3118 - Craig Thomas Rural Hospital and Provider Equity Act of 2008; sections 132, 145, 161-167

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

HR 493 and S 358 - Genetic Information Nondiscrimination Act of 2007; Title I HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 1432 and S. 316 - Preserve Access to Affordable Generics Act; all aspects HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects HR 2567 and S 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects HR 3193 - Access to Community Pharmacy Preservation Act of 2007; all aspects HR 3800 - Promoting Health Information Technology Act; all aspects HR 3932 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects HR 5629 - Pathway for Biosimilars Act; all aspects HR 5683 - Government Accountability Office Act of 2008, section 721 HR 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or the PRO(TECH) Act of 2008; all aspects S 28 - Generics First Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects S 596 - Safe Internet Pharmacy Act of 2007; section 511(c); all aspects S 976 - Genomics and Personalized Medicine Act of 2007; all aspects S 980 - Online Pharmacy Consumer Protection Act of 2007; all aspects S 1408 - Health Information Technology Act of 2007; all aspects S 1507 - Access to Medicare Data Act of 2007; all aspects S 1693 - Wired for Health Care Quality Act; all aspects S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects S. 1814 - Health Information Privacy and Security Act; all aspects S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects S 2161 - Community Pharmacy Fairness Act of 2007; all aspects

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Medicare Part D, Prompt Payment to Pharmacies, Antitrust Exemption for Pharmacists, IVIG Payments, Tracking or Pedigree of Prescription Drugs, Reimportation of Prescription Drugs, Medicare Demonstration Project for Durable Medical Equipment HR 2567 and S 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 3700 Fair Medicaid Drug Payment Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 Pharmaceutical Market Access Act of 2007; all aspects S 273 Prescription Drug and Health Improvement Act of 2007; all aspects S 1507 Access to Medicare Data Act of 2007; all aspects S 2219 Medicare Prescription Drug Savings and Choice Act of 2007; all aspects

Client expense: Not reported · Firm income: $60,000

Health information technology, Electronic prescribing, Genetic Nondiscrimination, Inappropriate Use of Human Growth Hormone, Contract Disclosure Regulations, Comparative Effectiveness, 340B Program, Confidentiality of Health Information, Generic Drugs, Generic Biologics, Internet Pharmacies, Off-label Use of Prescription Drugs HR 493 and S 358 - Genetic Information Nondiscrimination Act of 2007; Title I HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 1432 and S. 316 - Preserve Access to Affordable Generics Act; all aspects HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects HR 2567 and S 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects HR 3193 - Access to Community Pharmacy Preservation Act of 2007; all aspects HR 3800 - Promoting Health Information Technology Act; all aspects HR 3932 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects H.R. 5629 - Pathway for Biosimilars Act; all aspects S 28 - Generics First Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects S 596 - Safe Internet Pharmacy Act of 2007; section 511(c); all aspects S 976 - Genomics and Personalized Medicine Act of 2007; all aspects S 980 - Online Pharmacy Consumer Protection Act of 2007; all aspects S 1408 - Health Information Technology Act of 2007; all aspects S 1507 - Access to Medicare Data Act of 2007; all aspects S 1693 - Wired for Health Care Quality Act; all aspects S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects S. 1814 - Health Information Privacy and Security Act; all aspects S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects

Client expense: Not reported · Firm income: $60,000

H.Con.Res. 99: Budget Resolution HR 1535: Children's Health First Act HR 2147: Healthy Kids Act HR 2851 Michelle's Law HR 2900: FDA Amendments Act HR 3341 Quality Health Care Coalition Act of 2007 HR 3425 Cancer Screening Coverage Act of 2007 HR 4460 Health Care Choice Act of 2007 HR 758 Breast Cancer Patient Protection Act of 2007 HR 836 Cyber-Security Enhancement and Consumer Data Protection Act of 2007 HR 948 Social Security Number Protection Act of 2007 HR 976 Childrens Health Insurance Program Reauthorization Act of 2007 S 1102: Part D Equity for Low-Income Seniors Act S 1224: Children's Health Insurance Program Reauthorization Act S 1408 Health Information Technology Act of 2007 S 1507: Access to Medicare Data Act S 1588 Children's Access to Reconstructive Evaluation and Surgery Act S 1893 Childrens Health Insurance Program Reauthorization Act of 2007 S 358 Genetic Nondiscrimination Act of 2007 S 40 National Insurance Act of 2007 S 400 Michelle's Law S 401: Keep Children Covered Act S 459 Breast Cancer Patient Protection Act of 2007 S 493 Genetic Information Nondiscrimination Act of 2007 S 495 Personal Data Privacy and Security of 2007 S 895: Children's Health First Act S ConRes. 21: Budget Resolution H.R.2761Terrorism Risk Insurance Extension Act Federal Terrorism Risk Insurance HR 2761 Terrorism Risk Insurance Act of 2007: All provisions related to housing and multifamily property insurance S. 558 Mental Health Parity Act H.R. 1424 Paul Wellstone Mental Health and Addiction Equity Act H.R. 493 Genetic Information Nondiscrimination Act H.R. 1424 Paul Wellstone Mental Health and Addiction Equity Act H.R. 3997 Tax Relief Act with MHP Extension S. 46 Affordability in the Individual Market Act S. 558 Mental Health Parity Act S. 2477 Health Care Choice Act H.R.920 To amend the National Flood Insurance Act of 1968 to provide for the national flood insurance program to make available multiperil coverage for damage resulting from windstorms or floods, and for other purposes. S.2449 : A bill to amend chapter 111 of title 28, United States Code, relating to protective orders, sealing of cases, disclosures of discovery information in civil actions, and for other purposes. S.1782 : A bill to amend chapter 1 of title 9 of United States Code with respect to arbitration.

Client expense: Not reported · Firm income: $75,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 1663: Medicare Mental Health Modernization Act S 1103: Helping Fill the Medicare Rx Gap Act S 1108: Medicare Part D Outreach and Enrollment Enhancement Act S 1701: TMA/Medicare Advantage S 1883 Accountability and Transparency in Medicare Marketing Act of 2007 S 2499 Medicare, Medicaid & SCHIP Extension Act of 2007. S 1218 Medicare for All Act HR 2034 Medicare for All Act S 130 Medicare Cost Contract Extension & Retirement Act of 2007 S3 Medicare Prescription Drug Price Negotiation Act of 2007 HR 4 Medicare Prescription Drug Price Negotiation Act of 2007 HR 976 Children's Health Insurance Program Reauthorization Act of 2007 HR 971 Community Pharmacy Fairness Act of 2007 Medicare; Medicare Advantage; Medicare Part D; Comparative Effectiveness Research: HR3162 "Children's Health and Medicare Protection Act of 2007" Section 904 only; HR2184 "Enhanced Health Care Value for All Act"; Medicare Electronic Helath Records; Pay for Performance S. 2785: Save Medicare Act of 2008 H.R. 4296/S. 2408: Medicare Electronic Medication and Safety Protection (E-MEDS) Act H.R. 5613: Protecting the Medicaid Safety Net Act of 2008; Comparative Effectiveness; Medicare Reform HR 1474 Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007 HR 2567 Medicare Home Infusion Therapy Coverage Act of 2007 HR 2606 340B Program Improvement and Integrity Act of 2007 HR 2914 Medicare IVIG Access Act of 2007 HR 3932 Medicare Prescription Drug Savings and Choice Act of 2007 S 870 Medicare Home Infusion Therapy Consolidated Coverage Act of 2007 S 1376 340B Program Improvement and Integrity Act of 2007 S 1507 Access to Medicare Data Act of 2007 S 1544 Medicare Quality Enhancement Act of 2007 Competitive Bidding Contract Disclosure Regulations 340B Program H.R. 2945 Medicare Advantage Truth in Advertising Act H.Con Res. 312 Budget Resolution S. 1954 Pharmacy Access Improvement Act S. 2408 Medicare Electronic Medication and Safety Protection Act H.Con Res. 70 Budget Resolution S 1893/HR 976 Children's Health Insurance Program Reauthorization Act of 2007 H.R. 3162: Children's Health and Medicare Protection Act of 2007 S. 2499 Medicare, Medicaid & SCHIP Extension Act of 2007.

Client expense: Not reported · Firm income: $75,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare Part D, Prompt Payment to Pharamcies, Antitrust Exemption for Pharmacists, IVIG Payments, Tracking or Pedigree of Prescription Drugs, Reimportation of Prescription Drugs, Medicare Demonstration Project for Durable Medical Equipment. HR 2567 and S 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 3700 Fair Medicaid Drug Payment Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 Pharmaceutical Market Access Act of 2007; all aspects S 273 Prescription Drug and Health Improvement Act of 2007; all aspects S 1507 Access to Medicare Data Act of 2007; all aspects S 2219 Medicare Prescription Drug Savings and Choice Act of 2007; all aspects

Client expense: $880,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), SENATE

Health Information Technology, Electronic Prescribing, Genetic Nondiscrimination, Inappropriate use of Human Growth Hormone, Contract Dislcosure Regulations, Comparative Effectiveness, 340B Program, Confidentiality of Health Information, Generic Drugs, Generic Biologics, Internet Pharmacies, Off-Label Use of Prescription Drugs. HR 493 and S 358 - Genetic Information Nondiscrimination Act of 2007; Title I HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 1432 and S. 316 - Preserve Access to Affordable Generics Act; all aspects HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects HR 2567 and S 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects HR 3193 - Access to Community Pharmacy Preservation Act of 2007; all aspects HR 3800 - Promoting Health Information Technology Act; all aspects HR 3932 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects H.R. 5629 - Pathway for Biosimilars Act; all aspects S 28 - Generics First Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects S 596 - Safe Internet Pharmacy Act of 2007; section 511(c); all aspects S 976 - Genomics and Personalized Medicine Act of 2007; all aspects S 980 - Online Pharmacy Consumer Protection Act of 2007; all aspects S 1408 - Health Information Technology Act of 2007; all aspects S 1507 - Access to Medicare Data Act of 2007; all aspects S 1693 - Wired for Health Care Quality Act; all aspects S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects S. 1814 - Health Information Privacy and Security Act; all aspects S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects S 2161 - Community Pharmacy Fairness Act of 2007; all aspects

Client expense: $880,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), SENATE

HR 2945 Medicare Advantage Truth in Advertising Act; HR 4296 - Medicare Electronic Medication and Safety Protection Act; H.Con.Res.312- Budget Resolution; S. 1507 - Access to Medicare Data Act; S. 1544 - Medicare Quality Enhancement Act; S. 1954 - Pharmacy Access Improvement Act; S. 2408 - Medicare Electronic Medication and Safety Protection Act; H.Con. Res. 70 Budget Resolution

Client expense: $1,120,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Deposit Insurance Corporation (FDIC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of

MMM (Legislative Issues): H.R. 4: Medicare Prescription Drug Price Negotiation Act (Dingell); H.R. 976: Childrens Health Insurance Program Reauthorization Act (Rangel); H.R. 1535: Children's Health First Act (Dingell); H.R. 1663: Medicare Mental Health Modernization Act (Stark) (continued) H.R. 1990: Medicare Cost Contract Extension and Refinement Act (Pomeroy); H.R. 2147: Healthy Kids Act (Emanuel); H.R. 2945: Medicare Advantage Truth in Advertising Act (Stark); H.R. 3025: Medicare Prescription Drug Savings for Our Seniors Act (Doggett); H.R. 3061: Medicare Part D Drug Class Protection Act (Doggett); H.R. 3162: Childrens Health and Medicare Protection Act (Dingell); H.R. 3932: Medicare Prescription Drug Savings and Choice Act (Berry); H.R. 3963: Childrens Health Insurance Program Reauthorization Act (Dingell); H.R. 4296: Medicare Electronic Medication and Safety Protection Act (Schwartz); H.R. 5268: Medicaid FMAP (Pallone); H.R. 5480: Medicare Funding Warning Response Act (Hoyer-Boehner); H.R. 5613: Protecting the Medicaid Safety Net Act (Dingell); S. 3: Medicare Prescription Drug Price Negotiation Act (Reid); S. 130: Medicare Cost Contract Extension and Refinement Act (Allard); S. 401: Keep Children Covered Act (Rockefeller); S. 706: Medicare Advantage Stabilization Fund (Feingold); S. 799: Community Choice Act (Harkin); S. 895: Children's Health First Act (Clinton); S. 1102: Part D Equity for Low-Income Seniors Act (Bingaman); S. 1103: Helping Fill the Medicare Rx Gap Act (Bingaman); S. 1107: Home and Community Services Copayment Equity Act (Smith); S. 1108: Medicare Part D Outreach and Enrollment Enhancement Act (Smith); S. 1200: Indian Health Care Improvement Act (includes Medicaid/MA provisions); S. 1224: Children's Health Insurance Program Reauthorization Act (Rockefeller); S. 1507: Access to Medicare Data Act (Grassley); S. 1544: Medicare Quality Enhancement Act (Gregg); S. 1827: Pharmacist Access and Recognition in Medicare Act (Cochran); S. 1893: Childrens Health Insurance Program Reauthorization Act (Baucus); S. 1954: Pharmacy Access Improvement Act (Baucus); S. 2219: Medicare Prescription Drug Savings and Choice Act (Durbin); S. 2408: Medicare Electronic Medication and Safety Protection Act (Kerry); S. 2620: Medicaid FMAP (Rockefeller); S. 2662: Medicare Funding Warning Response Act (Baucus-Gregg); S. Con. Res. 70: Budget Resolution; (Conrad); H. Con. Res. 312: Budget Resolution, section 201 (Spratt). MMM (Regulatory Issues) Ongoing implementation issues for the Medicare Advantage (MA) and Medicare Part D prescription drug programs, including risk adjustment methodology and data issues, bidding and payment issues (including MA coding intensity, Part D reinsurance, and low income subsidies), benefit design rules, SSA and CMS premium withhold processing issues, systems issues affecting enrollment and disenrollment processing, enrollment rules, marketing materials review and approval, marketing activities, including conduct of brokers and agents and plan sponsor marketing staff and issues raised by CMS about Private Fee-for-Service (PFFS) plan marketing, measurement and oversight of plan performance including Special Needs Plans (SNPs), grievance and appeals processes, Medicare/Medicaid integration issues for Special Needs Plans (SNPs), Part D prescription drug event data reporting, Part D formulary rules, Part D pharmacy access standards, and other operational issues; Medicare creditable drug coverage reporting requirements; implementation issues for the Medicare Retiree Drug Subsidy program; functionality of the Medicare Personal Plan Finder and Drug Plan Finder; National Medicare Education program; ongoing implementation issues for the Medicare cost plan program including enrollment, marketing materials review and approval, systems issues affecting enrollment and disenrollment processing, payment and other operational issues; Medicare demonstration program on performance-based payments for physician groups; physician quality reporting inititiative; issues relating to Medicare coverage policy and national coverage decisions; Medicare clinical trials; Medicaid managed care regulations and policies, including the Medicaid managed care actuarial soundness standard, quality oversight, grievance and appeals processes, beneficiary information requirements, treatment of Medicaid health plan member hospital days in the upper payment limit calculation; policies affecting State Medicaid funding, including intergovernmental transfers (IGTs) and federal matching funds for graduate medical education; coordination of benefits with state Medicaid programs; Medicaid prescription drug cost/rebate issues affecting Medicaid health plans; health plan-related State Childrens Health Insurance Program (SCHIP) issues, including eligibility and outreach issues; implementation of Medicaid changes made in Deficit Reduction Act of 2005, including documentation of citizenship requirements, state benefit flexibility options, and Medicaid managed care organization provider tax issues; standards for electronic prescribing; and health information technology standards and policies.

Client expense: $1,820,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Office of Personnel Management (OPM), SENATE, Social Security Administration (SSA), Treasury, Dept of

H.Con.Res. 99: Budget Resolution HR 1535: Children's Health First Act HR 2147: Healthy Kids Act HR 2761 Terrorism Risk Insurance Revision and Extension Act of 2007 HR 2851 Michelle's Law HR 2900: FDA Amendments Act HR 3341 Quality Health Care Coalition Act of 2007 HR 3425 Cancer Screening Coverage Act of 2007 HR 4460 Health Care Choice Act of 2007 HR 758 Breast Cancer Patient Protection Act of 2007 HR 836 Cyber-Security Enhancement and Consumer Data Protection Act of 2007 HR 948 Social Security Number Protection Act of 2007 HR 976 Childrens Health Insurance Program Reauthorization Act of 2007 S 1102: Part D Equity for Low-Income Seniors Act S 1224: Children's Health Insurance Program Reauthorization Act S 1408 Health Information Technology Act of 2007 S 1507: Access to Medicare Data Act S 1588 Children's Access to Reconstructive Evaluation and Surgery Act S 1893 Childrens Health Insurance Program Reauthorization Act of 2007 S 358 Genetic Nondiscrimination Act of 2007 S 40 National Insurance Act of 2007 S 400 Michelle's Law S 401: Keep Children Covered Act S 459 Breast Cancer Patient Protection Act of 2007 S 493 Genetic Information Nondiscrimination Act of 2007 S 495 Personal Data Privacy and Security of 2007 S 895: Children's Health First Act S ConRes. 21: Budget Resolution

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2945 Medicare Advantage Truth in Advertising Act H.R. 4296 Medicare Electronic Medication and Safety Protection Act H.Con Res. 312 Budget Resolution S. 1507 Access to Medicare Data Act S. 1544 Medicare Quality Enhancement Act S. 1954 Pharmacy Access Improvement Act S. 2408 Medicare Electronic Medication and Safety Protection Act H.Con Res. 70 Budget Resolution Comparative Effectiveness

Client expense: Not reported · Firm income: $75,000

HR 1474 Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007 HR 2567 Medicare Home Infusion Therapy Coverage Act of 2007 HR 2606 340B Program Improvement and Integrity Act of 2007 HR 2914 Medicare IVIG Access Act of 2007 HR 3932 Medicare Prescription Drug Savings and Choice Act of 2007 HR 4296 Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007 S 870 Medicare Home Infusion Therapy Consolidated Coverage Act of 2007 S 1376 340B Program Improvement and Integrity Act of 2007 S 1507 Access to Medicare Data Act of 2007 S 1544 Medicare Quality Enhancement Act of 2007 Competitive Bidding Contract Disclosure Regulations Comparative Effectiveness 340B Program

Client expense: Not reported · Firm income: $75,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare Advantage - HR 3963, Children's Health Insurance Program Reauthorization Act of 2007; HConRes 312, CONCURRENT RESOLUTION ON THE BUDGET FOR FISCAL YEAR 2009; SConRes 70, Setting forth the congressional budget for the United States Government for fiscal year 2009. Medicare issues - S 706, Medicare Advantage Stabilization Fund; S 130, Medicare Cost Contract Extension/Refinement; HR 1990, Medicare Cost Contract Extension/Refinement; HR 4, Medicare Prescription Drug Price Negotiation; S 3, Medicare Prescription Drug Price Negotiation; S 1102, Medicare Part D Equity for Low Income Seniors; S 1103, Helping Fill the Medicare RX Gap; S 1107, Home-Community Services Copayment Equity; S 1108, Medicare Part D Outreach /Enrollment; HR 1663, Medicare Mental Health Modernization; HR 1535, Children's Health First Act; S 895, Children's Health First Act; S 1224, Children's Health Insurance Program Reauthorization; HR 2147, Healthy Kids Act; HR 2945, Medicare Advantage Truth in Advertising; S 799, Community Choice Act; S 401, Keep Children Covered Act; S 1544, Medicare Quality Enhancement Act; S 1507, Access to Medicare Data; S 1827, Pharmacist Access/Recognition in Medicare; HR 3025, Medicare Prescription Drug Savings for Seniors; HR 3061, Medicare Part D Drug Class Protection; HR 3162, Children's Health and Medicare Protection; HR 976, Children's Health Insurance Program Reauthorization; S 1893, Children's Health Insurance Program Reauthorization; S 1954, Pharmacy Access Improvement; S 2219, Medicare Prescription Drug Savings and Choice; HR 3932, Medicare Prescription Drug Savings and Choice; S 2408, Medicare Electronic Medication and Safety Protection; HR 4296, Medicare Electronic Medication and Safety Protection; S 1200, Indian Health Care Improvement Act; HR 5480, Medicare Funding Warning Response Act; S 2662, Medicare Funding Warning Response Act; HR 5268, Medicaid FMAP; S 2620, Medicaid FMAP

Client expense: Not reported · Firm income: $100,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office

See attached list S.2300, Lower PRICED Drugs Act S.1893/H.R.976, Childrens Health Insurance Program Reauthorization Act of 2007 S.358, Genetic Information Nondiscrimination Act S.910, Healthy Families Act S.885, Community Pharmacy Fairness Act of 2007 S.628, Critical Access to Health Information Technology Correction Act S.558, Mental Health Parity Act of 2007 S.495, Personal Data Privacy and Security Act of 2007 S.400, Michelles Law S.397, Tax Equity and Affordability Act of 2007 S.3585, HSA Improvement and Expansion Ac of 2006 S.358, Genetic Information Nondiscrimination Act of 2007 S.3488, Tax-free Healthcare Savings, Access, and Portability Act S.334, Healthy Americans Act S.325/H.R. 506, Health Partnership Act of 2007 S.273, Prescription Drug Health Improvement Act of 2007 S.2601/H.R.4551, Health Care Choices for Seniors Act S.2549, Health Savings Account Affordability Act S.1753, Healthy Workforce Act of 2007 S.1739, TAA Health Coverage Improvement Act of 2007 S.1693, Wired for Health Care Quality Act S.1690, Small Business Health Insurance Options Act of 2007 S.158, Access to Affordable Health Care Act S.1576, Minority Health Improvement and Health Disparity Elimination Act of 2007 S.1556, Tax Equity for Domestic Partner and Health Plan Beneficiaries Act S.1507, Access to Medicare Data Act of 2007 S.1503, Healthy America Act of 2005 S.1455, National Health Information Technology and Privacy Advancement Act of 2007 S.1408, Health Information Technology Act of 2007 S.1342, Healthy Lifestyles and Prevention (HeLP) America Act S.1224, Childrens Health Insurance Program (CHIP) Reauthorization Act of 2007 S.1223.IS, Information Technology for Health Care Quality Act S.1221, Countdown to Coverage Act of 2007 S.1178, Securing Access, Value, and Equality in Health Care Act S.1169, State-Based Health Care Reform Act S.1082, Prescription Drug User Fee Amendments of 2007 S.1067, Healthy Places Act of 2007 S.1050, Promoting Wellness for Individuals with Disabilities Act of 2007 S.1023, A bill to eliminate the remainder of funding shortfalls for the State Children's Health Insurance Program (SCHIP) for fiscal 2007 S.1022, A bill to eliminate the remainder of funding shortfalls for the State Children's Health Insurance Program (SCHIP) for fiscal 2007 S.1019, Universal Health Care Choice and Access Act S.099, Small Business Health Care Tax Credit Act S.004, Healthy America Act 2005 S.1218, Medicare for All Act H.R.914, Tax Equity and Affordability Act of 2007 H.R.847, Healthcare Disclosure Act H.R.2737, Health Care Relief Act of 2007 H.R.2639, Promoting Health for Future Generations Act of 2007 H.R.2633, Healthy Lifestyles and Prevention (HeLP) America Act H.R.2412, Equity in Prescription Insurance and Contraceptive Coverage Act of 2007 H.R.2351, Health Coverage, Affordability, Responsibility, and Equity (Health CARE) Act of 2007 H.R.2302, Health Insurance Affordability Act of 2007 H.R.227, Health Care Tax deduction Act of 2007 H.R.2184, Enhanced Health Care Value for All Act of 2007 H.R.2132, Small Business Health Plans Act of 2007 H.R.2089, Securing Access, Value, and Equality in Health Care Act H.R.2047, Health Insurance for Life Act of 2007 H.R.1952, National Health Information Act of 2007 H.R.1820, Tax Equity for Health Plan Beneficiaries Act of 2007 H.R.1666, Health Care Price Transparency Promotion Act of 2007 H.R.1542, Healthy Families Act H.R.1489, A bill to eliminate the remainder of the funding shortfalls in the State Children's Health Insurance Program (SCHIP) for fiscal year 2007 H.R.1368, Personalized Health Information Act of 2007 H.R.1367, Paul Wellstone Mental Health and Addiction Equity Act of 2007 H.R.1329, Guaranteed Access for SCHIPs Target Population Act of 2007 H.R.1012, Small Business Growth Act of 2007 H.R.015, National Health Insurance Act H.R.4511, Flexible Health Savings Account Act H.R.4505, Health Care Incentive Act H.R.298, Flexible Spending Accounts Growth and Opportunities Act of 2007 H.R.636, HC Freedom of Choice Act H.R. 3162.IH, Children's Health and Medicare Protection Act of 2007

Client expense: $460,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Economic Council (NEC), SENATE, Transportation, Dept of (DOT), UNDETERMINED, White House Office

MMM (Legislative Issues): H.R. 4: Medicare Prescription Drug Price Negotiation Act (Dingell); H.R. 1535: Children's Health First Act (Dingell); H.R. 1663: Medicare Mental Health Modernization Act (Stark) (continued) H.R. 1990: Medicare Cost Contract Extension and Refinement Act (Pomeroy); H.R. 2147: Healthy Kids Act (Emanuel); H.R. 2206: Supplemental Appropriations Act (Obey); H.R. 2945: Medicare Advantage Truth in Advertising Act (Stark); H.Con.Res. 99: Budget Resolution (Spratt); S. 3: Medicare Prescription Drug Price Negotiation Act (Reid); S. 130: Medicare Cost Contract Extension and Refinement Act (Allard); S. 401: Keep Children Covered Act (Rockefeller); S. 706: Medicare Advantage Stabilization Fund (Feingold); S. 799: Community Choice Act (Harkin); S. 895: Children's Health First Act (Clinton); S. 1102: Part D Equity for Low-Income Seniors Act (Bingaman); S. 1103: Helping Fill the Medicare Rx Gap Act (Bingaman); S. 1107: Home and Community Services Copayment Equity Act (Smith); S. 1108: Medicare Part D Outreach and Enrollment Enhancement Act (Smith); S. 1224: Children's Health Insurance Program Reauthorization Act (Rockefeller); S. 1507: Access to Medicare Data Act (Grassley); S. 1544: Medicare Quality Enhancement Act (Gregg); S. 1701: TMA/Medicare Advantage (Baucus); S.Con.Res. 21: Budget Resolution (Conrad) MMM (Regulatory Issues) Ongoing implementation issues for the Medicare Advantage and Medicare Part D prescription drug programs, including risk adjustment methodology and data issues, bidding and payment (including Part D reinsurance and low income subsidies), benefit design rules, SSA and CMS premium withhold processing issues, systems issues affecting enrollment and disenrollment processing, enrollment rules, marketing materials review and approval, marketing activities, including conduct of brokers and agents and plan sponsor marketing staff and issues raised by CMS about Private Fee-for-Service (PFFS) plan marketing, measurement and oversight of plan performance, grievance and appeals processes, Medicare/Medicaid integration issues for Special Needs Plans (SNPs), Part D prescription drug event data reporting, Part D formulary rules, Part D pharmacy access standards, and other operational issues; Medicare creditable drug coverage reporting requirements; implementation issues for the Medicare Retiree Drug Subsidy program; functionality of the Medicare Personal Plan Finder and Drug Plan Finder; National Medicare Education program; ongoing implementation issues for the Medicare cost plan program including enrollment, marketing materials review and approval, systems issues affecting enrollment and disenrollment processing, payment and other operational issues; Medicare demonstration program on performance-based payments for physician groups; Medicare coverage policy and national coverage decisions; Medicare clinical trials; Medicaid managed care regulations and policies, including the Medicaid managed care actuarial soundness standard, quality oversight, grievance and appeals processes, beneficiary information requirements, treatment of Medicaid health plan member hospital days in the upper payment limit calculation; policies affecting State Medicaid funding, including intergovernmental transfers (IGTs) and federal matching funds for graduate medical education; coordination of benefits with state Medicaid programs; Medicaid prescription drug cost/rebate issues affecting Medicaid health plans; health plan-related State Children's Health Insurance Program (SCHIP) issues, including eligibility and outreach issues; implementation of Medicaid changes made in Deficit Reduction Act of 2005, including documentation of citizenship requirements, state benefit flexibility options, and Medicaid managed care organization provider tax issues; standards for electronic prescribing; and CMS RFI concerning health information technology.

Client expense: $3,420,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Office of Personnel Management (OPM), SENATE, Social Security Administration (SSA), Treasury, Dept of, UNDETERMINED

S. 706: Medicare Advantage Stabilization Fund H.R. 4: Medicare Prescription Drug Price Negotiation Act S. 3: Medicare Prescription Drug Price Negotiation Act S. 1102: Part D Equity for Low-Income Seniors Act S. 1103: Helping Fill the Medicare Rx Gap Act S. 1108: Medicare Part D Outreach and Enrollment Enhancement Act H.R. 1663: Medicare Mental Health Modernization Act S.Con.Res. 21: Budget Resolution H.Con.Res. 99: Budget Resolution H.R. 1535: Children's Health First Act S. 895: Children's Health First Act S. 1224: Children's Health Insurance Program Reauthorization Act H.R. 2147: Healthy Kids Act S. 1701: TMA/Medicare Advantage S. 401: Keep Children Covered Act S. 1544: Medicare Quality Enhancement Act S. 1507: Access to Medicare Data Act H.R. 2058 Helping Fill the Medicare Rx Gap Act of 2007 S. 1218 Medicare for All Act H.R. 2034 Medicare for All Act H.R. 2065 Medicare Drug Savings through Choice Act of 2007 S. 137 Preserving Medicare for All Act of 2007 H.R. 205 Medicare Prescription Drug Enrollment Extension Act of 2007 H.R. 1521 Universal Health Act of 2007: Repeal of the Late Enrollment Penalty in Medicare Part D H.R. 118 To amend part D title XVIII of the Social Security Act to authorize the Secretary of Health and Human Services to negotiate prices for part D covered drugs for Medicare beneficiaries H.R. 2056 Medicare Part D Improvement Act of 2007 S. 1507 Access to Medicare Data Act of 2007 H.R. 1536 Prescription Coverage Now Act of 2007 S. 28 Generics First Act of 2007 H.R. 932 To amend part D of title XVIII of the Social Security Act to limit the monthly amount of prescription drug cost-sharing for full-benefit dual eligible individuals H.R. 2945 Medicare Advantage Truth in Advertising Act of 2007 S. 273 Prescription Drug and Health Improvement Act of 2007 S. 1108 Medicare Part D Outreach and Enrollment Enhancement Act of 2007 HR 205 Medicare Prescription Drug Enrollment Extension Act of 2007 HR 1218 Medicare Prescription Drug Improvement Act HR 1521 Universal Health Act of 2007: Repeal of the Late Enrollment Penalty in Medicare Part D HR 2009 To repeal the Medicare cost containment provisions contained in subtitle A of title VIII of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003. HR 2043 Medicare for All Act HR 2058 Helping Fill the Medicare Rx Gap Act of 2007 HR 2065 Medicare Drug Savings Through Choice Act of 2007 HR 2149 Healthcare Eligibility for Late Participants (HELP) in Medicare Part D Act of 2007 HR 2307 Preventing Medicare Seniors from being Confused due to Abusive Marketing (Prevent Medicare SCAMs) Act of 2007 HR 2827 Medicare Equity and Accessibility Act of 2007 S 130 Medicare Cost Contract Extension and Refinement Act of 2007 S 137 Preserving Medicare for All Act of 2007 S 173 Medicare Health Savings Accounts Act of 2007 S 1338 Access to Medicare Imaging Act of 2007

Client expense: Not reported · Firm income: $120,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 4-Drug Price Negotiation; HConRes 99-Budget Resolution; HR 1535-Children's Health First Act; HR 2147-Healthy Kids Act; S 3-Drug Price Negotiation; SConRes 21-Budget Resolution; S 401-Keep Children Covered Act; S 1102-Part D Equity for Low-Income Seniors Act; S 1103-Helping Fill the Medicare Rx Gap Act; S 1224-Children's Health Insurance Program Reauthorization Act; S 1507-Access to Medicare Data Act; S 1544-Medicare Quality Enhancement Act; S 1701-TMA/Medicare Advantage

Client expense: $2,320,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Deposit Insurance Corporation (FDIC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of

S. 1507, "Access to Medicare Data Act of 2007," issues related to the transfer of Part D data to Congressional Support Agencies and to Research Centers. Issues related to changes to formularies by PDPs and MA-PDs during the plan year. S. 3 "Medicare Prescription Drug Price Negotiation Act of 2007," issues related to transfer of Part D data from CMS to Congressional Support Agencies, and to require that a mail order pharmacy inform a Part D enrollee of the cost of a drug at the time of "purchase."

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

H.R.914, Tax Equity and Affordability Act of 2007 H.R.847, Healthcare Disclosure Act H.R.2737, Health Care Relief Act of 2007 H.R.2639, Promoting Health for Future Generations Act of 2007 H.R.2633, Healthy Lifestyles and Prevention (HeLP) America Act H.R.2412, Equity in Prescription Insurance and Contraceptive Coverage Act of 2007 H.R.2351, Health Coverage, Affordability, Responsibility, and Equity (Health CARE) Act of 2007 H.R.2302, Health Insurance Affordability Act of 2007 H.R.227, Health Care Tax deduction Act of 2007 H.R.2184, Enhanced Health Care Value for All Act of 2007 H.R.2132, Small Business Health Plans Act of 2007 H.R.2089, Securing Access, Value, and Equality in Health Care Act H.R.2047, Health Insurance for Life Act of 2007 H.R.1952, National Health Information Act of 2007 H.R.1820, Tax Equity for Health Plan Beneficiaries Act of 2007 H.R.1666, Health Care Price Transparency Promotion Act of 2007 H.R.1542, Healthy Families Act H.R.1489, A bill to eliminate the remainder of the funding shortfalls in the State Children's Health Insurance Program (SCHIP) for fiscal year 2007 H.R.1368, Personalized Health Information Act of 2007 H.R.1367, Paul Wellstone Mental Health and Addiction Equity Act of 2007 H.R.1329, Guaranteed Access for SCHIP’s Target Population Act of 2007 H.R.1012, Small Business Growth Act of 2007 H.R.015, National Health Insurance Act H.R.4511, Flexible Health Savings Account Act H.R.4505, Health Care Incentive Act H.R.298, Flexible Spending Accounts Growth and Opportunities Act of 2007 H.R.636, HC Freedom of Choice Act S.2300, Lower PRICED Drugs Act S.1893/H.R.976, Children’s Health Insurance Program Reauthorization Act of 2007 S.358, Genetic Information Nondiscrimination Act S.910, Healthy Families Act S.885, Community Pharmacy Fairness Act of 2007 S.628, Critical Access to Health Information Technology Correction Act S.558, Mental Health Parity Act of 2007 S.495, Personal Data Privacy and Security Act of 2007 S.400, Michelle’s Law S.397, Tax Equity and Affordability Act of 2007 S.3585, HSA Improvement and Expansion Ac of 2006 S.358, Genetic Information Nondiscrimination Act of 2007 S.3488, Tax-free Healthcare Savings, Access, and Portability Act S.334, Healthy Americans Act S.325/H.R. 506, Health Partnership Act of 2007 S.273, Prescription Drug Health Improvement Act of 2007 S.2601/H.R.4551, Health Care Choices for Seniors Act S.2549, Health Savings Account Affordability Act S.1753, Healthy Workforce Act of 2007 S.1739, TAA Health Coverage Improvement Act of 2007 S.1693, Wired for Health Care Quality Act S.1690, Small Business Health Insurance Options Act of 2007 S.158, Access to Affordable Health Care Act S.1576, Minority Health Improvement and Health Disparity Elimination Act of 2007 S.1556, Tax Equity for Domestic Partner and Health Plan Beneficiaries Act S.1507, Access to Medicare Data Act of 2007 S.1503, Healthy America Act of 2005 S.1455, National Health Information Technology and Privacy Advancement Act of 2007 S.1408, Health Information Technology Act of 2007 S.1342, Healthy Lifestyles and Prevention (HeLP) America Act S.1224, Children’s Health Insurance Program (CHIP) Reauthorization Act of 2007 S.1223.IS, Information Technology for Health Care Quality Act S.1221, Countdown to Coverage Act of 2007 S.1178, Securing Access, Value, and Equality in Health Care Act S.1169, State-Based Health Care Reform Act S.1082, Prescription Drug User Fee Amendments of 2007 S.1067, Healthy Places Act of 2007 S.1050, Promoting Wellness for Individuals with Disabilities Act of 2007 S.1023, A bill to eliminate the remainder of funding shortfalls for the State Children's Health Insurance Program (SCHIP) for fiscal 2007 S.1022, A bill to eliminate the remainder of funding shortfalls for the State Children's Health Insurance Program (SCHIP) for fiscal 2007 S.1019, Universal Health Care Choice and Access Act S.099, Small Business Health Care Tax Credit Act S.004, Healthy America Act 2005 S.1218, Medicare for All Act See attached list

Client expense: $460,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Economic Council (NEC), SENATE, Transportation, Dept of (DOT), White House Office

MMM (Regulatory Issues) Ongoing implementation issues for the Medicare Advantage and Medicare Part D prescription drug programs, including risk adjustment methodology and data issues, bidding and payment (including Part D reinsurance and low income subsidies), benefit design rules, SSA and CMS premium withhold processing issues, systems issues affecting enrollment and disenrollment processing, enrollment rules, marketing materials review and approval, marketing activities, including conduct of brokers and agents and plan sponsor marketing staff and issues raised by CMS about Private Fee-for-Service (PFFS) plan marketing, measurement and oversight of plan performance, grievance and appeals processes, Medicare/Medicaid integration issues for Special Needs Plans (SNPs), Part D prescription drug event data reporting, Part D formulary rules, Part D pharmacy access standards, and other operational issues; Medicare creditable drug coverage reporting requirements; implementation issues for the Medicare Retiree Drug Subsidy program; functionality of the Medicare Personal Plan Finder and Drug Plan Finder; National Medicare Education program; ongoing implementation issues for the Medicare cost plan program including enrollment, marketing materials review and approval, systems issues affecting enrollment and disenrollment processing, payment and other operational issues; Medicare demonstration program on performance-based payments for physician groups; Medicare coverage policy and national coverage decisions; Medicare clinical trials; Medicaid managed care regulations and policies, including the Medicaid managed care actuarial soundness standard, quality oversight, grievance and appeals processes, beneficiary information requirements, treatment of Medicaid health plan member hospital days in the upper payment limit calculation; policies affecting State Medicaid funding, including intergovernmental transfers (IGTs) and federal matching funds for graduate medical education; coordination of benefits with state Medicaid programs; Medicaid prescription drug cost/rebate issues affecting Medicaid health plans; health plan-related State Children’s Health Insurance Program (SCHIP) issues, including eligibility and outreach issues; implementation of Medicaid changes made in Deficit Reduction Act of 2005, including documentation of citizenship requirements, state benefit flexibility options, and Medicaid managed care organization provider tax issues; standards for electronic prescribing; and CMS RFI concerning health information technology. H.R. 1990: Medicare Cost Contract Extension and Refinement Act (Pomeroy); H.R. 2147: Healthy Kids Act (Emanuel); H.R. 2206: Supplemental Appropriations Act (Obey); H.R. 2945: Medicare Advantage Truth in Advertising Act (Stark); H.Con.Res. 99: Budget Resolution (Spratt); S. 3: Medicare Prescription Drug Price Negotiation Act (Reid); S. 130: Medicare Cost Contract Extension and Refinement Act (Allard); S. 401: Keep Children Covered Act (Rockefeller); S. 706: Medicare Advantage Stabilization Fund (Feingold); S. 799: Community Choice Act (Harkin); S. 895: Children's Health First Act (Clinton); S. 1102: Part D Equity for Low-Income Seniors Act (Bingaman); S. 1103: Helping Fill the Medicare Rx Gap Act (Bingaman); S. 1107: Home and Community Services Copayment Equity Act (Smith); S. 1108: Medicare Part D Outreach and Enrollment Enhancement Act (Smith); S. 1224: Children's Health Insurance Program Reauthorization Act (Rockefeller); S. 1507: Access to Medicare Data Act (Grassley); S. 1544: Medicare Quality Enhancement Act (Gregg); S. 1701: TMA/Medicare Advantage (Baucus); S.Con.Res. 21: Budget Resolution (Conrad) MMM (Legislative Issues): H.R. 4: Medicare Prescription Drug Price Negotiation Act (Dingell); H.R. 1535: Children's Health First Act (Dingell); H.R. 1663: Medicare Mental Health Modernization Act (Stark) (continued)

Client expense: $3,420,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Office of Personnel Management (OPM), SENATE, Social Security Administration (SSA), Treasury, Dept of

S. 1544 Medicare Quality Enhancement Act of 2007 H.R. 2065 Medicare Drug Savings through Choice Act of 2007 S. 73 Medicare Health Saving Accounts Act of 2007 H.R. 2307 Preventing Medicare Seniors from being Confused due Abusive Marketing (Prevent Medicare Scams) Act of 2007 H.R. 1990 Medicare Cost Contract Extension and Refinement Act of 2007 H.R. 2009 “To repeal the Medicare costs Containment Provisions […]” S. 1307 Medicare Provider Accountability Act S. 137 Preserving Medicare for All Act of 2007 H.R. 205 Medicare Prescription Drug Enrollment Extension Act of 2007 H.R. 1282 MediGap Access Improvement Act of 2007 H.R. 1219 Medicare Equity and Fairness in Fee-For-Service Reimbursement Act of 2007 H.R. 2149 Health Care Eligibility for Late Participants (HELP) in Medicare Act of 2007 S. 3 Medicare Prescription Drug Price and Negotiation Act of 2007 S.355 The Social Security and Medicare Solvency Efficiency Act H.R. 1277 Medicare Prescription Drug Benefits Drug Gap Elimination Act of 2007 H.R. 4 Medicare Prescription Drug Price Negotiation Act of 2007 H.R. 2827 Medicare Equity and Accessibility Act of 2007 S. 250 Medicare Enhancements for Needed Drug Act of 2007 H.R. 1218 Medicare Prescription Drug and Improvement Act of 2007 H.R. 1521 Universal Health Act of 2007: Repeal of the Late Enrollment Penalty in Medicare Part D H.R. 118 To amend part D title XVIII of the Social Security Act to authorize the Secretary of Health and Human Services to negotiate prices for part D covered drugs for Medicare beneficiaries H.R. 1310 Relief and Elimination of the Medicare Enrollment Deadline Penalty Act of 2007 H.R. 2056 Medicare Part D Improvement Act of 2007 S. 1507 Access to Medicare Data Act of 2007 H.R. 1536 Prescription Coverage Now Act of 2007 S. 28 Generics First Act of 2007 H.R. 932 To amend part D of title XVIII of the Social Security Act to limit the monthly amount of prescription drug cost-sharing for full-benefit dual eligible individuals H.R. 2945 Medicare Advantage Truth in Advertising Act of 2007 H.R. 1046 Medicare Quality Improvement Organization Modernization Act of 2007 H.R. 2058 Helping Fill the Medicare Rx Gap Act of 2007 S. 1103 Helping Fill the Medicare Rx Gap Act of 2007 S. 1108 Medicare Part D Outreach and Enrollment Enhancement Act of 2007

Client expense: $460,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 1521 Universal Health Act of 2007: Repeal of the Late Enrollment Penalty in Medicare Part D HR 2009 To repeal the Medicare cost containment provisions contained in subtitle A of title VIII of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003. HR 2043 Medicare for All Act HR 2058 Helping Fill the Medicare Rx Gap Act of 2007 HR 2065 Medicare Drug Savings Through Choice Act of 2007 HR 2149 Healthcare Eligibility for Late Participants (HELP) in Medicare Part D Act of 2007 HR 2307 Preventing Medicare Seniors from being Confused due to Abusive Marketing (Prevent Medicare SCAMs) Act of 2007 HR 2827 Medicare Equity and Accessibility Act of 2007 S 3 Medicare Prescription Drug Price Negotiation Act of 2007 S 130 Medicare Cost Contract Extension and Refinement Act of 2007 S 137 Preserving Medicare for All Act of 2007 S 173 Medicare Health Savings Accounts Act of 2007 S 1218 Medicare for All Act S 1338 Access to Medicare Imaging Act of 2007 S 1507 Access to Medicare Data Act of 2007 S 1544 Medicare Quality Enhancement Act of 2007 HR 4 Medicare Prescription Drug Price Negotiation Act of 2007 HR 205 Medicare Prescription Drug Enrollment Extension Act of 2007 HR 1218 Medicare Prescription Drug Improvement Act

Client expense: Not reported · Firm income: $105,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2034 Medicare for All Act H.R. 2065 Medicare Drug Savings through Choice Act of 2007 S. 137 Preserving Medicare for All Act of 2007 H.R. 205 Medicare Prescription Drug Enrollment Extension Act of 2007 S. 3 Medicare Prescription Drug Price Negotiation Act of 2007 H.R. 4 Medicare Prescription Drug Price Negotiation Act of 2007 H.R. 1218 Medicare Prescription Drug and Improvement Act of 2007 H.R. 1521 Universal Health Act of 2007: Repeal of the Late Enrollment Penalty in Medicare Part D H.R. 118 To amend part D title XVIII of the Social Security Act to authorize the Secretary of Health and Human Services to negotiate prices for part D covered drugs for Medicare beneficiaries H.R. 2056 Medicare Part D Improvement Act of 2007 S. 1507 Access to Medicare Data Act of 2007 H.R. 1536 Prescription Coverage Now Act of 2007 S. 28 Generics First Act of 2007 H.R. 932 To amend part D of title XVIII of the Social Security Act to limit the monthly amount of prescription drug cost-sharing for full-benefit dual eligible individuals H.R. 2945 Medicare Advantage Truth in Advertising Act of 2007 S. 273 Prescription Drug and Health Improvement Act of 2007 S. 1102 Part D Equity for Low Income Seniors Act of 2007 S. 1108 Medicare Part D Outreach and Enrollment Enhancement Act of 2007 H.R. 2058 Helping Fill the Medicare Rx Gap Act of 2007 S. 1103 Helping Fill the Medicare Rx Gap Act of 2007 S. 1218 Medicare for All Act

Client expense: Not reported · Firm income: $90,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE